These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 11835208)

  • 1. Cryogenic grinding of indomethacin polymorphs and solvates: assessment of amorphous phase formation and amorphous phase physical stability.
    Crowley KJ; Zografi G
    J Pharm Sci; 2002 Feb; 91(2):492-507. PubMed ID: 11835208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A study of amorphous molecular dispersions of indomethacin and its sodium salt.
    Tong P; Zografi G
    J Pharm Sci; 2001 Dec; 90(12):1991-2004. PubMed ID: 11745758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancement of the physical stability of amorphous indomethacin by mixing it with octaacetylmaltose. inter and intra molecular studies.
    Kaminska E; Adrjanowicz K; Zakowiecki D; Milanowski B; Tarnacka M; Hawelek L; Dulski M; Pilch J; Smolka W; Kaczmarczyk-Sedlak I; Kaminski K
    Pharm Res; 2014 Oct; 31(10):2887-903. PubMed ID: 24831310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. X-ray Absorption Near-Edge Spectroscopy Analysis of Indomethacin in Crystalline Forms and in Amorphous Solid Dispersions.
    Suzuki H; Iwata M; Ito M; Noguchi S
    Mol Pharm; 2021 Sep; 18(9):3475-3483. PubMed ID: 34372659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of protective colloids on the induction of polymorphic changes in indomethacin agglomerates after solvent evaporation from o/w emulsions.
    Lin SY; Chen KS; Teng HS
    J Microencapsul; 1999; 16(1):39-47. PubMed ID: 9972501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Using the low-frequency Raman spectroscopy to analyze the crystallization of amorphous indomethacin.
    Hédoux A; Paccou L; Guinet Y; Willart JF; Descamps M
    Eur J Pharm Sci; 2009 Sep; 38(2):156-64. PubMed ID: 19591926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of low concentrations of molecularly dispersed poly(vinylpyrrolidone) on indomethacin crystallization from the amorphous state.
    Crowley KJ; Zografi G
    Pharm Res; 2003 Sep; 20(9):1417-22. PubMed ID: 14567636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of surface crystallisation of amorphous indomethacin particles in physical drug-polymer mixtures.
    Priemel PA; Laitinen R; Barthold S; Grohganz H; Lehto VP; Rades T; Strachan CJ
    Int J Pharm; 2013 Nov; 456(2):301-6. PubMed ID: 24012867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Indomethacin: new polymorphs of an old drug.
    Surwase SA; Boetker JP; Saville D; Boyd BJ; Gordon KC; Peltonen L; Strachan CJ
    Mol Pharm; 2013 Dec; 10(12):4472-80. PubMed ID: 24025118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved physical stability of amorphous state through acid base interactions.
    Telang C; Mujumdar S; Mathew M
    J Pharm Sci; 2009 Jun; 98(6):2149-59. PubMed ID: 18837038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-plasticizing effect of amorphous indomethacin induced by specific intermolecular interactions with PVA copolymer.
    Ueda H; Aikawa S; Kashima Y; Kikuchi J; Ida Y; Tanino T; Kadota K; Tozuka Y
    J Pharm Sci; 2014 Sep; 103(9):2829-2838. PubMed ID: 24890320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular dynamics simulation of amorphous indomethacin-poly(vinylpyrrolidone) glasses: solubility and hydrogen bonding interactions.
    Xiang TX; Anderson BD
    J Pharm Sci; 2013 Mar; 102(3):876-91. PubMed ID: 23280486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Solid-State NMR Investigation of Drug-Excipient Interactions and Phase Behavior in Indomethacin-Eudragit E Amorphous Solid Dispersions.
    Lubach JW; Hau J
    Pharm Res; 2018 Feb; 35(3):65. PubMed ID: 29464409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of compression on non-isothermal crystallization behaviour of amorphous indomethacin.
    Ayenew Z; Paudel A; Rombaut P; Van den Mooter G
    Pharm Res; 2012 Sep; 29(9):2489-98. PubMed ID: 22638868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physical characterization and stability of amorphous indomethacin and ranitidine hydrochloride binary systems prepared by mechanical activation.
    Chieng N; Aaltonen J; Saville D; Rades T
    Eur J Pharm Biopharm; 2009 Jan; 71(1):47-54. PubMed ID: 18644443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular dynamics simulation of amorphous indomethacin.
    Xiang TX; Anderson BD
    Mol Pharm; 2013 Jan; 10(1):102-14. PubMed ID: 23116319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective Acceleration of Crystal Growth of Indomethacin Polymorphs by Low-Concentration Poly(ethylene oxide).
    Shi Q; Zhang J; Zhang C; Jiang J; Tao J; Zhou D; Cai T
    Mol Pharm; 2017 Dec; 14(12):4694-4704. PubMed ID: 29125764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stabilization of low glass transition temperature indomethacin formulations: impact of polymer-type and its concentration.
    Chokshi RJ; Shah NH; Sandhu HK; Malick AW; Zia H
    J Pharm Sci; 2008 Jun; 97(6):2286-98. PubMed ID: 17879977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Solid state characterization of azelnidipine-oxalic acid co-crystal and co-amorphous complexes: The effect of different azelnidipine polymorphs.
    Pan Y; Pang W; Lv J; Wang J; Yang C; Guo W
    J Pharm Biomed Anal; 2017 May; 138():302-315. PubMed ID: 28237872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thermal analysis and FTIR spectral curve-fitting investigation of formation mechanism and stability of indomethacin-saccharin cocrystals via solid-state grinding process.
    Zhang GC; Lin HL; Lin SY
    J Pharm Biomed Anal; 2012 Jul; 66():162-9. PubMed ID: 22497855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.